Screener Summaries Updates Institutions Sign In More Updates › Financing › BYAH Financing · Jun 15, 2026
Park Ha Biological Technology Co., Ltd. closed a best-efforts offering of 1,133,332 Class A ordinary shares and… BYAH Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. closed a best-efforts offering of 1,133,332 Class A ordinary shares and 200,000 pre-funded warrants at $1.50 per unit. The offering, which closed on June 15, 2026, generated approximately $2.0 million in gross proceeds for working capital and general corporate purposes. Park Ha Biological Technology Co., Ltd. is a biotechnology company based in China.
More from Park Ha Biological Technology Co., Ltd. On September 11, 2026, Park Ha Biological Technology Co., Ltd. closed a private investment in public equity (PIPE)… Sep 11, 2026 On August 3, 2026, Park Ha Biological Technology Co., Ltd. completed a private placement transaction with non-U.S.… Aug 3, 2026 Park Ha Biological Technology Co., Ltd. announced the successful passage of all resolutions at its Extraordinary… Jul 13, 2026 Park Ha Biological Technology Co., Ltd. filed a membership application with the Personal Care Products Council on July… Jul 1, 2026 Park Ha Biological Technology Co., Ltd. announced on June 29, 2026, that it is initiating cooperation with Amazon and… Jun 29, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
